{"id":"https://openalex.org/W2076482983","doi":"https://doi.org/10.3109/03639048309044701","title":"Azone\u00ae: A New Non-Toxic Enhancer of Cu'Taneous Penetration","display_name":"Azone\u00ae: A New Non-Toxic Enhancer of Cu'Taneous Penetration","alternate_titles":[],"publication_year":1983,"publication_date":"1983-01-01","ids":{"openalex":"https://openalex.org/W2076482983","doi":"https://doi.org/10.3109/03639048309044701","mag":"2076482983"},"language":"en","primary_location":{"id":"doi:10.3109/03639048309044701","doi":"https://doi.org/10.3109/03639048309044701","is_oa":false,"landing_page_url":"https://doi.org/10.3109/03639048309044701","pdf_url":null,"source":{"id":"https://openalex.org/S162444473","display_name":"Drug Development and Industrial Pharmacy","issn_l":"0363-9045","issn":["0363-9045","1520-5762"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug Development and Industrial Pharmacy","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2076482983"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5066520249","display_name":"Richard R. Stoughton","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I36258959","display_name":"University of California San Diego","ror":"https://ror.org/0168r3w48","country_code":"US","type":"education","lineage":["https://openalex.org/I36258959"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Richard R. Stoughton","raw_affiliation_strings":["Dept. of Dermatology, Univ. of California at San Diego, La Jolla, CA, 92103"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dept. of Dermatology, Univ. of California at San Diego, La Jolla, CA, 92103","institution_ids":["https://openalex.org/I36258959"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5113607581","display_name":"William O. McClure","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"William O. McClure","raw_affiliation_strings":["Nelson Research and Development, 19712 MacArthur Boulevard, Irvine, CA, 92715"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Nelson Research and Development, 19712 MacArthur Boulevard, Irvine, CA, 92715","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":9.5358,"has_fulltext":false,"cited_by_count":148,"citation_normalized_percentile":{"value":0.99338374,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"9","issue":"4","first_page":"725","last_page":"744"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10704","display_name":"Advancements in Transdermal Drug Delivery","score":1.0,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10704","display_name":"Advancements in Transdermal Drug Delivery","score":1.0,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10920","display_name":"Advanced Drug Delivery Systems","score":0.0,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10256","display_name":"Drug Solubulity and Delivery Systems","score":0.0,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/azone","display_name":"Azone","score":0.9900000095367432},{"id":"https://openalex.org/keywords/skin-penetration-enhancers","display_name":"skin penetration enhancers","score":0.6940000057220459},{"id":"https://openalex.org/keywords/transdermal-drug-delivery","display_name":"transdermal drug delivery","score":0.8289999961853027},{"id":"https://openalex.org/keywords/hydrophilic-drugs","display_name":"hydrophilic drugs","score":0.8009999990463257},{"id":"https://openalex.org/keywords/poorly-water-soluble-drugs","display_name":"poorly water-soluble drugs","score":0.8820000290870667},{"id":"https://openalex.org/keywords/molecular-weight","display_name":"molecular weight","score":0.5899999737739563},{"id":"https://openalex.org/keywords/emulsions","display_name":"emulsions","score":0.6269999742507935}],"concepts":[{"id":"https://openalex.org/C2776005048","wikidata":"https://www.wikidata.org/wiki/Q4832825","display_name":"Azone","level":4,"score":0.9976990818977356},{"id":"https://openalex.org/C80107235","wikidata":"https://www.wikidata.org/wiki/Q7162625","display_name":"Penetration (warfare)","level":2,"score":0.8021512627601624},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.7193909287452698},{"id":"https://openalex.org/C43617362","wikidata":"https://www.wikidata.org/wiki/Q170050","display_name":"Chromatography","level":1,"score":0.5221981406211853},{"id":"https://openalex.org/C77281830","wikidata":"https://www.wikidata.org/wiki/Q718608","display_name":"Dosage form","level":2,"score":0.4233302175998688},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.17597049474716187},{"id":"https://openalex.org/C50670333","wikidata":"https://www.wikidata.org/wiki/Q907651","display_name":"Permeation","level":3,"score":0.11016646027565002},{"id":"https://openalex.org/C41625074","wikidata":"https://www.wikidata.org/wiki/Q176088","display_name":"Membrane","level":2,"score":0.0791042149066925},{"id":"https://openalex.org/C42475967","wikidata":"https://www.wikidata.org/wiki/Q194292","display_name":"Operations research","level":1,"score":0.0},{"id":"https://openalex.org/C127413603","wikidata":"https://www.wikidata.org/wiki/Q11023","display_name":"Engineering","level":0,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.3109/03639048309044701","doi":"https://doi.org/10.3109/03639048309044701","is_oa":false,"landing_page_url":"https://doi.org/10.3109/03639048309044701","pdf_url":null,"source":{"id":"https://openalex.org/S162444473","display_name":"Drug Development and Industrial Pharmacy","issn_l":"0363-9045","issn":["0363-9045","1520-5762"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug Development and Industrial Pharmacy","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":9,"referenced_works":["https://openalex.org/W1989473793","https://openalex.org/W1995087152","https://openalex.org/W2001889699","https://openalex.org/W2025012202","https://openalex.org/W2046091662","https://openalex.org/W2076204925","https://openalex.org/W2081699868","https://openalex.org/W2141095211","https://openalex.org/W3021056057"],"related_works":["https://openalex.org/W2349418880","https://openalex.org/W2019840972","https://openalex.org/W2068787280","https://openalex.org/W2074522710","https://openalex.org/W2063580409","https://openalex.org/W2282387154","https://openalex.org/W3197436669","https://openalex.org/W2030749147","https://openalex.org/W2001889699","https://openalex.org/W2031979845"],"abstract_inverted_index":{"Azonem":[0],"(1-dodecylazacycloheptan-2-one)":[1],"enhances":[2],"the":[3,6,35,46,90,93],"penetration":[4],"through":[5],"skin":[7],"of":[8,11,14,34,48,50,85,105],"a":[9,39,77],"nutnber":[10],"drugs.":[12,31],"Penetration":[13],"both":[15,89],"hydrophobic":[16],"and":[17,92,97],"hydrophilic":[18,30],"molecules":[19],"is":[20,73],"enhanced,":[21],"althouyh":[22],"more":[23],"dramatic":[24],"enhancements":[25,68],"are":[26],"usually":[27],"seen":[28,70],"with":[29,88],"Molecular":[32],"weights":[33],"drugs":[36],"considered":[37],"seems":[38],"relatively":[40],"minor":[41],"concern,":[42],"at":[43],"least":[44],"in":[45,59,65,80],"ranye":[47],"MW":[49],"less":[51],"than":[52],"1000":[53],"daltono.":[54],"Azone":[55,86],"need":[56],"not":[57],"be":[58,100,109],"solution":[60],"to":[61,108],"exert":[62],"its":[63],"influence;":[64],"fact,":[66],"good":[67],"arc":[69],"when":[71],"Rzone":[72],"employed":[74],"only":[75],"as":[76],"shaken":[78],"em117.sion":[79],"water.":[81],"The":[82],"optimum":[83],"concentration":[84],"varies":[87],"drug":[91],"formulation":[94],"being":[95],"examined,":[96],"cannot":[98],"now":[99],"predicted.In":[101],"general,":[102],"however,":[103],"concentrations":[104],"2-10%":[106],"appear":[107],"appropriate":[110],"for":[111],"most":[112],"formulations.":[113]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2076482983","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":2},{"year":2023,"cited_by_count":1},{"year":2020,"cited_by_count":2},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":1}],"updated_date":"2026-11-17T12:49:18.490984","created_date":"2016-06-24T00:00:00"}
